ENTRY       D10761                      Drug
NAME        Polatuzumab vedotin (USAN);
            Polatuzumab vedotin (genetical recombination) (JAN);
            Polatuzumab vedotin-piiq;
            Polivy (TN)
PRODUCT     POLIVY (Genentech)
FORMULA     C6670H10317N1745O2087S40
EXACT_MASS  149533.3646
MOL_WEIGHT  149625.3253
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01FX14
            Product: D10761<JP/US>
EFFICACY    Antineoplastic
  DISEASE   Diffuse large B-cell lymphoma [DS:H02434]
  TYPE      Antibody-drug conjugate
COMMENT     See Vedotin [DR:D09691]
TARGET      CD79B [HSA:974] [KO:K06507]
  PATHWAY   hsa04662(974)  B cell receptor signaling pathway
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
                L01FX Other monoclonal antibodies and antibody drug conjugates
                 L01FX14 Polatuzumab vedotin
                  D10761  Polatuzumab vedotin (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Monoclonal Antibody/Antibody-Drug Conjugate
               Polatuzumab Vedotin
                D10761  Polatuzumab vedotin (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D10761  Polatuzumab vedotin (USAN); Polatuzumab vedotin (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D10761  Polatuzumab vedotin
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD79B
                 D10761  Polatuzumab vedotin (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10761
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10761
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10761
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10761
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10761
DBLINKS     CAS: 1313206-42-6
            PubChem: 295369351
///
